Yes...'patience is a virtue' but after 20 years of 'investing' in ASX stocks I think I am burnt out so have become more and
more impetuous. Doesn't help to have a stupendous (also insert... ludicrous, crazy, ridiculous...) amount riding on this
& added to 100 fold since 2002.
Like most Companies on the ASX whether in Biotec or Mining or whatever, the due diligence process can be incredibly drawn out
and we will probably never understand the lengthy process and regulations any Company has to do or go through as they all have
different criteria depending on what Industry they are involved in.
Anyway, Greg has responded back which is much appreciated (email posted below as nothing in it that we all don't already know and
he would approve as shows he is still working hard behind the scenes). Will help reassure everyone that things are still happening
under surface but I owe him an apology for ever doubting his ongoing commitment to see through a successful outcome for Invion.
I have emailed him to clarify the bit about having 'a presence at the meeting' (ie the one I'm harping on about...?)
Thanks for your continuing support of the company.
Please don’t think for a moment we have given up trying as you suggested. As I mentioned at the AGM, we are continuing our discussions and working hard towards a positive outcome and we are in discussions constantly with parties that have interest in our assets. We will have a presence at the meeting you described below and we have attended this meetings and many others over the past few years. The meetings are most useful to set up initial contacts with companies and representatives of key biotechnology funds and we have established these contacts over the past years. Now, the approach is much more targeted and one/one contact with these individuals rather than a public forum to push discussions along under confidentiality as parties complete due diligence on our clinical programs.
Happy to chat anytime if you wanted to discuss on the phone as well.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)